Sarissa Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Sarissa Capital Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-689,091	Closed	-$3.58M	–	21
2015 Q3	$3.58M	Hold	689,091	–	–	0.88%	14
2015 Q2	$4.7M	Hold	689,091	–	–	1.08%	12
2015 Q1	$4.92M	Hold	689,091	–	–	1.04%	13
2014 Q4	$5.13M	Buy	689,091 +299,091	+77%	+$2.54M	1.82%	10
2014 Q3	$3.61M	Buy	390,000 +161,874	+71%	+$2.19M	1.39%	11
2014 Q2	$4.25M	Buy	228,126 +126,301	+124%	+$2.15M	1.45%	11
2014 Q1	$1.89M	Buy	+101,825	New	+$1.94M	0.65%	14

Other funds holding KIN

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Sarissa Capital Management's KIN Position: Q4 2015 in Review

Sarissa Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q4 2015, closing a stake of 689,091 shares — an estimated $3.58M sold.

Sarissa Capital Management first reported a position in KIN in Q1 2014 and held it in 7 quarters. The position peaked at $5.13M in Q4 2014. 50 funds tracked by Wall St. Rank hold KIN as of Q4 2015.

Sarissa Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
Sarissa Capital Management sold 689,091 Kindred Biosciences, Inc. shares in Q4 2015, an estimated $3.58M.
Sarissa Capital Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 7 quarters.
Sarissa Capital Management's Kindred Biosciences, Inc. position peaked at $5.13M in Q4 2014.
50 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2015.

Based on Sarissa Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.